Ahmad Shabsigh
Overview
Explore the profile of Ahmad Shabsigh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2122
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pierorazio P, Kleinmann N, Shabsigh A, Hu B, Raman J, Kaimakliotis H, et al.
J Urol
. 2024 Nov;
213(3):313-322.
PMID: 39561384
Purpose: We evaluate long-term outcomes of primary chemoablation using a mitomycin reverse thermal gel (UGN-101) in patients with low-grade upper tract urothelial carcinoma. Materials And Methods: Patients who participated in...
2.
Elbialy A, Kappala D, Desai D, Wang P, Fadiel A, Wang S, et al.
Cells
. 2024 Jun;
13(12.
PMID: 38920635
Prostate cancer (PCa) remains a leading cause of mortality among American men, with metastatic and recurrent disease posing significant therapeutic challenges due to a limited comprehension of the underlying biological...
3.
Schaeffer E, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al.
J Natl Compr Canc Netw
. 2024 Apr;
22(3):140-150.
PMID: 38626801
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic...
4.
Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al.
J Natl Compr Canc Netw
. 2023 Oct;
21(10):1067-1096.
PMID: 37856213
The NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, post-treatment...
5.
6.
Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al.
J Natl Compr Canc Netw
. 2022 Dec;
20(12):1288-1298.
PMID: 36509074
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate...
7.
Venkatramani V, Reis I, Gonzalgo M, Castle E, Woods M, Svatek R, et al.
JAMA Netw Open
. 2022 Feb;
5(2):e2148329.
PMID: 35171260
Importance: No data exist on time to recovery of patient-reported and performance-related measures of functional independence after radical cystectomy (open or robotic). Objective: To determine recovery of functional independence after...
8.
Matin S, Pierorazio P, Kleinmann N, Gore J, Shabsigh A, Hu B, et al.
J Urol
. 2022 Jan;
207(4):788.
PMID: 34985341
No abstract available.
9.
Matin S, Pierorazio P, Kleinmann N, Gore J, Shabsigh A, Hu B, et al.
J Urol
. 2021 Dec;
207(4):779-788.
PMID: 34915741
Purpose: Our goal was to evaluate long-term safety and durability of response to UGN-101, a mitomycin-containing reverse thermal gel, as primary chemoablative treatment for low-grade upper tract urothelial carcinoma. Materials...
10.
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
DAndrea D, Foerster B, Matin S, Ku J, Muilwijk T, Monteiro L, et al.
Eur Urol Open Sci
. 2021 Aug;
19:16-19.
PMID: 34337449
No abstract available.